drugset / Trial / NCT00003713

Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors

NCT00003713 ↗

Phase 1 Completed 35 enrolled Genzyme, a Sanofi Company
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of intoplicine in treating patients who have advanced or metastatic solid tumors.

Timeline

Start
1997-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject intoplicine Small molecule — Intravenous